DB06031InvestigationalSmall molecule
AZD-2836 is an inhibitor of the nonstructural protein 5A (NS5A). The drug is being investigated for treatment of hepatitis C because AZD-2836 has in vitro anti-HCV activity.
- Mechanism
- Curator reviewed
A-831 has shown potent activity in the replicon assay and has an excellent therapeutic index and good pharmacokinetic properties, as well as displaying a novel mechanism of action targeting the NS5a protein.
- Primary indication
- Investigated for use/treatment in hepatitis (viral, C).Curator reviewed
- Code names
- A-831 · AZD-2836
Resolves to
Compound
Targets
What you can answer from here — as of January 11, 2025
Which drugs share a target with AZD-2836, and which of those have an active Phase 3 trial?
Create a free account or log in to explore the full data card.
Create Account